A detailed history of Bank Of America Corp transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Bank Of America Corp holds 20,917 shares of AMRN stock, worth $11,086. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,917
Previous 10,128 106.53%
Holding current value
$11,086
Previous $6,000 116.67%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.57 - $0.8 $6,149 - $8,631
10,789 Added 106.53%
20,917 $13,000
Q2 2024

Aug 14, 2024

BUY
$0.63 - $1.07 $94 - $160
150 Added 1.5%
10,128 $6,000
Q1 2024

May 15, 2024

SELL
$0.82 - $1.35 $27,057 - $44,545
-32,997 Reduced 76.78%
9,978 $8,000
Q4 2023

Feb 14, 2024

BUY
$0.66 - $0.91 $12,878 - $17,756
19,513 Added 83.17%
42,975 $37,000
Q2 2023

Aug 14, 2023

BUY
$1.12 - $1.49 $7,000 - $9,312
6,250 Added 36.31%
23,462 $27,000
Q1 2023

May 12, 2023

SELL
$1.19 - $2.19 $4,558 - $8,389
-3,831 Reduced 18.21%
17,212 $25,000
Q4 2022

Feb 10, 2023

BUY
$1.07 - $1.34 $4,391 - $5,499
4,104 Added 24.23%
21,043 $25,000
Q3 2022

Nov 14, 2022

SELL
$1.09 - $1.67 $312,423 - $478,667
-286,627 Reduced 94.42%
16,939 $18,000
Q2 2022

Aug 12, 2022

SELL
$1.13 - $3.69 $40,161 - $131,146
-35,541 Reduced 10.48%
303,566 $452,000
Q1 2022

May 16, 2022

SELL
$2.85 - $3.73 $30,751 - $40,246
-10,790 Reduced 3.08%
339,107 $1.12 Million
Q4 2021

Feb 08, 2022

SELL
$3.24 - $5.18 $185,784 - $297,026
-57,341 Reduced 14.08%
349,897 $1.18 Million
Q3 2021

Nov 15, 2021

SELL
$3.94 - $5.84 $273,881 - $405,955
-69,513 Reduced 14.58%
407,238 $2.08 Million
Q2 2021

Sep 13, 2021

BUY
$4.26 - $6.5 $2.03 Million - $3.1 Million
476,751 New
476,751 $2.09 Million

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $214M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.